KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. D0· CIK 0001877184 Healthcare & Medical Devices

$29.42 +0.66 (+2.29%)

Oct 26 4:00 PM ET · prev $28.76

Market cap

$1.7B

Small cap

Consensus

Buy

86% Buy or better · 14 analysts

Median target

$30.00

+2% · range $28.00–34.00

1 year

+8.7%

from $27.07 · Oct 27

30 days

+4.6%

from $28.13

52-week range

$17.87–29.42

at the high

Avg volume 20D

401.3K

shares / day

Short interest

🔒 Subscribers only

Insider net

−$9.5M

0 buyers · 11 sellers · since Jul 15

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 13 reports · 90 days

Balance 3 bearish · 1 bullish · 2 mixed · 7 neutral oldest → newest, height = score

Avg score

·High conf. 5/13

Strongest BULLISH Evercore ISI Group Initiates KMTS at Outperform — PT $34 (+14.3%)

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Mar 17 Kestra Medical Technologies reported strong Q3 FY26 financial result…
S Jul 30 to Aug 7 5 days of insider sells: $5.0M by 5 insiders, avg $23.91
S Aug 17 1 insider sell $412.2K at $27.48
S Sep 8 4 insiders sell $413.9K at $25.20
S Sep 21 1 insider sell $97.3K at $24.26
S Sep 30 1 insider sell $97.5K at $29.28
S Oct 20 to Oct 21 2 days of insider sells: $3.2M by 2 insiders, avg $27.49
A Oct 20 Evercore ISI Group initiates

Signal stack

Where each data set points today.

InsidersBEARISH

11 insiders sold $9.5M.
InstitutionsBULLISH

Q2 2026: 16 added (1 new), 7 trimmed or exited. Largest new: Point72 Asset Management, $13.4M.
AnalystsBULLISH

12 of 14 rate it Buy or better. Median target $30.00 (+2%).
EstimatesFALLING

Current-quarter EPS estimate −$0.545 → −$0.605 over 90 days. 2 up, 0 down in 30 days.
TrendUPTREND

11% above its 50-day average. New closing high $29.42 on Oct 26.

Who's buying

13F· Q2 2026

new positions

exits

$13.4M

in new stakes

Fund	Move	Shares	Value
Point72 Asset Management, L.P.	NEW	526,626	$13.4M
Schonfeld Strategic Advisors LLC	DOUBLED	286,231	$7.3M
Nuveen, LLC	DOUBLED	96,015	$2.4M
Quantinno Capital Management LP	DOUBLED	80,370	$2.0M
Corient Private Wealth LP	DOUBLED	60,614	$1.5M
MORGAN STANLEY	TRIM	53,423	$1.4M
TUDOR INVESTMENT CORP ET AL	ADD	49,977	$1.3M
NEW YORK STATE COMMON RETIREMENT FUND	ADD	45,686	$1.2M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

14 analysts

Buy 86% rate it Buy or better

Strong Buy6Buy6Hold2Sell0Strong Sell0

12-month targets · 8 analysts

$29.42 $28.00 $30.00 $34.00

Price is inside the target range. Median implies +2%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Oct 20, 2026	Evercore ISI Group INITIATE	INITIATE	Outperform
Sep 15, 2026	BTIG REITERATE	REITERATE	Buy
Sep 2, 2026	BTIG REITERATE	REITERATE	Buy
Aug 10, 2026	JP Morgan INITIATE	INITIATE	Overweight
Jul 21, 2026	Oppenheimer INITIATE	INITIATE	Perform
Jul 15, 2026	BTIG MAINTAIN	MAINTAIN	Buy

Insider ledger

Form 4

bought · 0 insiders

$9.5M

sold · 11 insiders

Date	Insider	Type	Value
Oct 21, 2026	Umberger Traci S See Remarks	SELL	$101.0K
Oct 21, 2026	Umberger Traci S See Remarks	SELL	$2.6M
Oct 21, 2026	Umberger Traci S See Remarks	EXERCISE	$1.7M
Oct 20, 2026	Webster Brian Daniel See Remarks	SELL	$393.1K
Oct 20, 2026	Webster Brian Daniel See Remarks	SELL	$50.3K
Sep 30, 2026	COHEN RAYMOND W Director	SELL	$97.5K
Sep 21, 2026	Kwo Elizabeth Director	SELL	$97.3K
Sep 9, 2026	Kwo Elizabeth Director	AWARD	7,217 sh

Earnings setup

Estimates

−$0.60

EPS estimate, this quarter

−11%

estimate change, 90 days

2↑ 0↓

revisions, 30 days

Current-quarter EPS estimate

−$0.545

90d

−$0.615

60d

−$0.615

30d

−$0.605

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.60	-$0.61–-$0.60	+1.6%	$32.1M
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only